Launch excellence, Metabolic Bone Phase III approval, new indication (TIO) and LC-FAOD product launches. Identified and led sales training needs for rapidly expanding, tenured, and highly specialized metabolic bones disease sales team. - National, POA and Huddle Sales Meetings - Successful Distance Launches – TIO & Dojolvi - Design, develop curriculum & programs - Developed and Implemented Field Sales Trainers - RD Coaching Enhance Training - Commercial Ops and Needs Analysis - Business planning and training analysis - Build Effective Teams - Genetic Testing & Genetic Counseling Training

Product Launch Training Leader Development of training programs, multiple operations projects, and new product launch priorities. Established project management disciplined to deliver on tactics in a fast-paced environment. Responsible for customized Selling Model and Account Management training. Enhanced by customer based instructional design, development, and execution of training materials to effectively align launch strategies and field sales implementation. Train and prepare new hires on complex sales, clinical knowledge, and business tools MSL/Medical Manager training – Neuromyelitis Optica Spectrum Disorder rare disease training

Initiated the development of learning management infrastructure, training curriculum and contributing to field personnel developmental program. Focused on field sales training needs for rapidly expanding, tenured, and specialized liver disease sales team. Execute on launch excellence in order generate sustainable revenue, customer value, and enhanced selling experience for all.Cross-functional collaborations between Medical Affairs, sales, marketing, legal and compliance teams, ensuring alignment and consistency of strategies throughout Intercept Pharmaceuticals. Collaborate in the training strategies of innovative, life-altering therapies for patients with PBC, a debilitating rare disease. Initiatives executed in the rare disease market include:• Product Launch – OCALIVA PI –May 2016 and Sales/Marketing Campaign September 2016• “Interconnect” Hub Services – Process Trainings - Managed Market collaboration • Learning Performance Platform (LMS) – Enhanced Metrics and Requirements• Created product related materials OCALIVA Integrated Sales Training Modules • Launch and Training Field Directional Communications

Designed, implemented, and currently lead US and International sales training department for rapidly expanding, sophisticated, and seasoned rare disease sales team and nurse educators. Results include increased revenue, value, and optimization of the customer experience due to consistency in messaging and targeted selling skills. Leader in cross functional collaborations between executive team, sales, marketing, international global team training to ensure appropriate and consistent messaging to practitioners and patients. Collaborate in the development and commercialization of innovative, life-altering therapies for patients with debilitating often fatal, rare diseases. Initiatives developed for this highly sophisticated rare disease market include: New Product Launch – MYALEPT Aegerion Crew Award – New Product Integration and Launch Excellence Market Access Director Training Mexico and Canada Sales Training Launch – May/June 2014 Japan Market Development Training LatAm pre-launch training – Brazil, Argentina, Columbia and Chile – November 2014 Leading all US and Global Plan of Action Meetings - Design, content, and product focus initiatives that motivate and educate cross-functional and global teams

Service and Solutions that address the specific need of the BioPharmaceutical industry providing measurable results and achieving the highest level of customer experience. Expertise span across field sales management, product launch strategies, marketing, achieving top-level performance through business development, business analytics, and consultative selling.

Healthcare contact-center services, alternative detailing, virtual multi-channel strategies, and marketing support services. Led marketing strategies, sales planning, and compliance guidance to meet industry regulatory standards. Consulted on brand promotional strategy, sales training, customer engagement design, and tactics.  Business development - full line of enterprise business services: Adverse Event Reporting and Product Quality Complaints (PQC) Patient Coaching Counseling Services Access and Reimbursement Contact Center Inbound and Outbound calls Virtual Health Strategies – e-Detailing, v-sampling, voucher, coupons and HCP services

Directed a team that interface with Sales and Marketing business leaders for launch planning, sales strategy, market development, tactical implementation, and management of promotional speaker programs for Neurology, Oncology, HIV, Vaccines, and Cardiovascular franchises. Managed development of policy and procedures for global implementation and management of promotional medical education programs. Commercial operations; Co-Directed and led highly complex Project Management – Outsourcing of Merck Med Ed platform/CRM KOL Management, contracts and speaker web services resulting in a $3.2M value capture projected through 2015. Led value saving initiative reducing Medical Educational invitation costs from $5M in 2007 to $250K in 2010. Special Achievement Award – Strategic and Tactical excellence of Med Ed initiative addressing major market event through web streaming platforms and innovative promotional campaign

Acute Care Specialty Sales in oncology anti-emetic supportive care, myelodysplastic syndromes(Hematology), and implantable chemotherapy wafers. Centers of Excellence include - Fox Chase, UPMC, Roswell, The Johns Hopkins, Thomas Jefferson, Georgetown, and Hackensack Medical Center. Nationally Largest Volume Aloxi Sales 2006 Total - Acute Care Division Aloxi - 3rd Nationally -Percent to Plan 105.5% 4th Quarter 2006 Gliadel – 2nd Nationally - Percent to Plan - 4th Quarter 2006 Centers of Excellence -Fox Chase, UPMC, Roswell, The Johns Hopkins

Acute Care Specialty Sales in oncology Gliadel, an implantable chemotherapy wafers. Centers of Excellence include - Fox Chase, UPMC, Roswell, The Johns Hopkins, Thomas Jefferson, Georgetown, and Hackensack Medical Center.

Senior Marketing Manager, Medical Strategies Group Marketing Manager of Advisory Board and Thought Leader Market Research; led cross-functional team to effectively coordinate and integrate scientific and medical content as part of the marketing mix to inform strategic choices for ZOCOR Business franchise and Profit Plan by interacting, developing National Thought Leaders, and on occasion interacting with Hospital leaders. Developed and implemented individual strategic plans for Diabetes and Lipid Advisory Boards.  Led cross-functional teams to the design and develop content for Thought Leader Market Research to ensure timely input based on internal strategies, sales targets and anticipate competitive events, specifically in endocrinology and cardiovascular for 2003 and 2004 Profit Plans.

Business management of an eight state market. Led strategic sales initiative of Hospital “HUB and Spoke” business model and developed specialty cardiovascular start-up division of Aggrastat sales team, acute care hospital specialty sales force. Advance clinical sales, market development and employee development while exceeding all objectives. 2002 Business Manager of the Year – “Market Share Leader” December 2001- Highest market share Nationally, second highest dollar volume, 3rd smallest market potential – 101.8% PPO Y-T-D 2001 - Fit and Feasibility Committee  2000 -Nationally Highest Dollar Volume -2nd Market Share Nationally District 108% vs. Nation 104% 1999 - District 1st Market Share Nationally – 2nd –PPO 119% 1999 - Master Club Award  1998 - District 1st Market Share – 2nd – PPO 116% 1998, 1999 and 2000 selected for Marketing Project Teams

Business management of tri-state market, Ohio, Upstate New York, Northwestern PA. and Northern Ohio of newly formed biotech start-up. Led and developed eleven primary care representatives to become biotech acute care specialists to achieve top tier sales performance.  District ranked 6th Nationally for Retavase (IV Bolus)  1997 Sales Training Task force 1996 “Stretch Goal” AwardInstitutional Manage Care Specialist National Leader in Cardiac T, Troponin cardiac marker Corporate Career Development Program September 95 - November 95 Nationally Ranked 1st in Demadex sales (IMC Sales Feb.95) 1994 President Club ranked 1st IMC - Hospital Sales  Member of the Cardiac T Advisory Committee (CAT) and Sales Advisory Team (SAT)

Accountable for portfolio sales, speaker development, and implementation of clinical studies in assigned teaching institutions in New York City. Accountable in developing sales in Emergency Room, Dialysis Centers and Outpatient Clinics associated with teaching institution.  Nationally ranked 1st in Combined Targeted Products Nationally ranked 1st - President’s Club 7th in Nation - Atrovent Hospital Sales